Zang, C.X., Liu, R.J., Zhao, W.G., Sun, Y., Tang, S.F. and Sun, C.G. (2019) Research Progress of Breast Cancer Stem Cell Related Signal Pathway and Its Inhibitor. Journal of Chinese Oncology, 25, 27-31.

has been cited by the following article:

• TITLE: Epithelial-Mesenchymal Transition and Breast Cancer Stem Cells in Breast Cancer Progression

  AUTHORS: Wanyue Han, Qingshan Li, Qing Zhang, Fan Xu

  KEYWORDS: Epithelial-Mesenchymal Transition, Breast Cancer Stem Cells, E-Cadherin, Vimentin, Signaling Pathway

  JOURNAL NAME: Advances in Breast Cancer Research, Vol.11 No.2, April 27, 2022

  ABSTRACT: Breast cancer stem cells (BCSCs) are a small subpopulation of cancer cells having the ability of self-renewing and multi-lineage differentiation, which have also been termed as “tumor-initiating cells”. And in recent years, the role of epithelial mesenchymal transition (EMT) in malignant tumors has been valued. This paper will briefly review and discuss the relationship between BCSCs and EMT.